Inventor · disambiguated record
Thomas Macallister
Also filed as: MACALLISTER THOMAS · MACALLISTER THOMAS W
21 granted patents·36 pending applications·52 citations·filing 1992–2025
93Inventor score
Files withWOOLSEY PHARMACEUTICALS INC31REMEDY PHARMACEUTICALS INC9MARTIN PHARMACEUTICALS INC6BIOGEN CHESAPEAKE LLC3ME MEDICAL ENZYMES AG3
Top patents by PatentIndex Score
57 records- 0197US12251389B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·6 cites·30 claims
- 0295US12251388B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·4 cites·14 claims
- 0395US11311553B1Methods of treating 4-repeat tauopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·5 cites·18 claims
- 0494US11771704B1Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 3, 2023·1 cites·13 claims
- 0594US11642352B2Methods of treating wandering in Lewy dody dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·3 cites·12 claims
- 0691US11865119B2Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Jan 9, 2024·1 cites·27 claims
- 0789US11944633B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Apr 2, 2024·1 cites·25 claims
- 0887US11666583B2Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·1 cites·15 claims
- 0983US2025032441A1Method of Treating AscitesMARTIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1083US2025345347A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1182US12290522B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·22 claims
- 1281US10946011B2Stable oral liquid formulation of trimetazidineMARTIN PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·17 claims
- 1379US2025339448A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1479US2024100064A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1578US12337006B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Granted Jun 24, 2025·0 cites·30 claims
- 1678US12115167B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·0 cites·23 claims
- 1776US12268661B2Methods of treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·0 cites·12 claims
- 1876US11779588B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Oct 10, 2023·0 cites·16 claims
- 1975US2025268911A1Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's DiseaseWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2073US12329761B2Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 17, 2025·0 cites·12 claims
- 2173US2025228868A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2272US12274687B2Methods for treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 2372US6939541B2Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyaseUNIV SOUTH CAROLINA·Filed 2001·Granted Sep 6, 2005·5 cites·21 claims
- 2472US2023248739A1Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2572US2023226073A1Methods of treating proteinopathy associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2671US2021251943A1Method of Treating AscitesJACOBSON SVEN·Filed 2021·Application pending·0 cites
- 2770US7052689B2Method for producing therapeutically suitable glutaminaseME MEDICAL ENZYMES AG·Filed 2001·Granted May 30, 2006·3 cites·6 claims
- 2870US2022047607A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2970US2022088039A1Methods of medical treatment with sur1-trpm4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2021·Application pending·0 cites
- 3069US2021145788A1Methods of Treating AscitesMACALLISTER THOMAS W·Filed 2020·Application pending·0 cites
- 3168US2024299410A1Methods of treating familial amyotrophic lateral sclerosis by oral administration of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3268US2025161330A1Methods of medical treatment with sur1-trpm4 channel inhibitorsREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3368US2024423998A1Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3467US6312939B1Genetically engineered glutaminase and its use in antiviral and anticancer therapyME MEDICAL ENZYMES AG·Filed 1992·Granted Nov 6, 2001·21 cites·17 claims
- 3567US2021401853A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3665US2025381197A1Regimen for Treating Amyotrophic Lateral Sclerosis Having Onset 24 Months Prior to TreatmentWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3762US2021196707A1Stable Oral Liquid Formulation of TrimetazidineMACALLISTER THOMAS·Filed 2021·Application pending·0 cites
- 3861US12128053B2Taste-masking oral formulations of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·8 claims
- 3961US2024415846A1Method of treating amyotrophic lateral sclerosis and dosing regimen for sameWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4061US2024261298A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4161US2024252511A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4260US11304963B2Methods of medical treatment with SUR1-TRPM4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Apr 19, 2022·0 cites·11 claims
- 4359US2025345346A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4458US2024423997A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4558US2025144063A1Methods of Treating AscitesMARTIN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4654US2023080958A1Methods of treating pseudobulbar affect and other emotional disturbancesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4754US2023263806A1Methods of treating proteinopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4854US2023285409A1Methods of using rho kinase inhibitors to treat vascular dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4954US2023321114A1Methods of treating age-related cognitive declineWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5054US2006240414A1Genetically engineered glutaminase and its use in antiviral and anticancer therapyME MEDICAL ENZYMES AG·Filed 2006·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Macallister files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →